Jump Financial LLC bought a new stake in electroCore, Inc. (NASDAQ:ECOR – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm bought 14,149 shares of the company’s stock, valued at approximately $95,000.
Several other hedge funds have also recently bought and sold shares of the company. Jaffetilchin Investment Partners LLC increased its holdings in electroCore by 25.5% in the 1st quarter. Jaffetilchin Investment Partners LLC now owns 32,983 shares of the company’s stock valued at $221,000 after buying an additional 6,700 shares during the period. XTX Topco Ltd bought a new position in electroCore in the 1st quarter valued at about $90,000. Finally, Jane Street Group LLC bought a new position in electroCore in the 4th quarter valued at about $278,000. 26.74% of the stock is owned by institutional investors.
electroCore Trading Down 0.8%
Shares of electroCore stock opened at $4.89 on Friday. The firm has a market capitalization of $37.07 million, a PE ratio of -3.02 and a beta of 0.36. The firm’s 50 day moving average is $6.10 and its 200 day moving average is $7.10. electroCore, Inc. has a 1 year low of $4.16 and a 1 year high of $19.49.
Insider Activity
In related news, Director Thomas J. Errico purchased 15,000 shares of the firm’s stock in a transaction that occurred on Monday, August 11th. The shares were bought at an average cost of $4.47 per share, with a total value of $67,050.00. Following the acquisition, the director owned 281,401 shares of the company’s stock, valued at $1,257,862.47. This trade represents a 5.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 13.80% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Wall Street Zen lowered shares of electroCore from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, electroCore presently has a consensus rating of “Buy” and an average price target of $25.50.
View Our Latest Research Report on ECOR
electroCore Profile
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Further Reading
- Five stocks we like better than electroCore
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- Why Invest in 5G? How to Invest in 5G Stocks
- Lululemon Share Price Has Plenty of Room Left to Fall
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Want to see what other hedge funds are holding ECOR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for electroCore, Inc. (NASDAQ:ECOR – Free Report).
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.